Sdi Limited · ASX:SDI
Sdi — Shareholder Meeting (November 2024)
12 slides from Sdi's shareholder meeting presentation, Nov 28, 2024
Slide 1: FY24 AGM
FY24 AGM NOVEMBER 28, 2024
Slide 2: CEO's Address
CEO’S ADDRESS SAMANTHA CHEETHAM
Slide 3: 2024 Australian Export Health Award
2024 AUSTRALIAN EXPORT HEALTH AWARD • Winner of the 2023 Australian Export Award for International Health • Winner of the 2024 Victorian Export Award for International Health (3rd year in a row)
Slide 4: FY24 Performance Highlights
FY24 PERFORMANCE HIGHLIGHTS Improved Margins and operational efficiencies deliver record 12-month profit Record revenue of $111.2m New site capacity to drive (+ 3.1% pcp) future sales 62.1% Gross Profit Margin European Registration (+530 bps) Secured Continued Investment in EBITDA $21.9m Research, D
Slide 5: Sales by Business Unit
SALES BY BUSINESS UNIT Business unit performance reflects good European growth and favorable currency movements SALES BY BUSINESS UNIT (AUD MILLIONS) BUSINESS UNIT % SALES $120 50% $107.9 $111.2 $110 8.8 40% $100 $95.2 9.1 38% 37% 40% 34% 35% $90 $81.6 7.3 34% $79.6 $80 5.4 36.9 41.3 33% 5.1 $67.4 3
Slide 6: Sales by Product Category
SALES BY PRODUCT CATEGORY Strong Aesthetics performance continues to gain market share SALES BY CATEGORY (AUD millions) CATEGORY AS % SALES $120 $111.2 60% $110 $107.9 6.5 50% $95.1 6.5 46% 45% 47% $100 50% 45% 6.8 42% $90 31.0 $79.6 $81.6 31.3 $80 6.0 6.0 40% $67.3 29.8 32% 31% $70 29% 21.5 5.1 26.
Slide 7: Operational Update
OPERATIONAL UPDATE Milestone achievements underpin long term strategic plan • Upgrade to Montrose warehouse (investment of circa $3.0m) and warehousing relocation complete • Stela & Riva Cem Auto Mix progressing well, receiving great feedback from industry opinion leaders Composite Syringe Machine •
Slide 8: Securing of European Registration
SECURING OF EUROPEAN REGISTRATION EU MDR Certification • SDI have successfully secured its certification under the European Union’s Medical Device Regulation 2017/745 (MDR) as a manufacturer • SDI will be able to continue selling existing products into all European markets as planned • New Aesthetic
Slide 9: Project Montrose
PROJECT MONTROSE • New build expected to commence in the middle of 2025 • Montrose manufacturing upgrade: Project cost $56m with expected Nov 2024 – Final Design completed ROI (PBT/Rev) +20% underpinned by margin improvement Dec 2024 – Submit Planning Permit • Land and building $39m (reduced from $4
Slide 10: SDI – ESG Road Map
SDI – ESG ROAD MAP FY24 FY25 FY26-FY27 “Establishing” “Complying” “Enhancing” • Formalise the SDI ESG working • Review top suppliers on ESG • Review initiatives for emission group and its mandate. risks and incorporate into an reduction actions/strategies, updated Modern Slavery including how this r
Slide 11: Strategy & Outlook
STRATEGY & OUTLOOK o Aesthetics and Whitening products continue to be the focus for new product development • Stela exceeding expectations, on track to be one of our best product launches o Achieve manufacturing and logistic efficiencies through new site to help achieve sales of +$200m o Investment
Slide 12: Disclaimer
Disclaimer This Presentation contains summary information about SDI Limited (SDI) and its subsidiaries and their activities. The information in this Presentation does not purport to be complete. It should be read in conjunction with SDI’s other periodic and continuous disclosure announcements lodged